The latest biopharma awards press releases and news


Biopharma Logistics and Supply Chain Excellence Awards (BLSA) APAC Recognized Outstanding Achievements in Biologistics

The Biopharma Logistics and Supply Chain Excellence Awards (BLSA) APAC seeks to recognize exceptional Asian biologistics personnel, organizations, and technologies over the past year. Asia is home to thriving bioprocessing hubs and supports complex supply chains, making it an ideal region to honor top biologistics leaders in the industry.

BLSA 2023 Ceremony was held in conjunction with the 7th BioLogistics World Asia, a leading event for the biopharmaceutical supply chain industry in the region. The Awards applauded extraordinary leaders and trend-setters of today and inspired the innovators of tomorrow. This year’s ceremony proved to be an exciting and inspiring event as we celebrate the achievements of the best and brightest in biologistics.

“BLSA 2023 is a platform that celebrates excellence in biologistics across Asia,” said Aloysius Chong, Project Director of the IMAPAC Biopharma Awards. “We are honored to recognize the best in the industry and inspire future innovators to continue pushing the boundaries of biologistics.”

For more information on the Biopharma Logistics and Supply Chain Excellence Awards (BLSA) APAC, please visit


IMAPAC is a leading event management company specializing in the biopharmaceutical industry. With over 12 years of experience, IMAPAC has successfully organized more than 50 industry events, attracting over 15,000 participants from around the world. IMAPAC’s events are renowned for their high-quality content, prestigious speakers, and networking opportunities.


Charmaine Poh
[email protected]


IMAPAC has successfully held the Asia-Pacific Bioprocessing Excellence Awards 2023, recognizing outstanding achievements and contributions in bioprocessing. The awards ceremony attracted over 80 participants from more than 40 biopharmaceutical companies across the Asia-Pacific region, with 53 categories such as Best Biomanufacturing Team and Best Emerging Biotech Company.

The Biopharma R&D and Clinical Trials Awards (BRCTA) 2023 recognized exceptional Asian clinical trials leaders, organizations, and technologies over the past year. The awards include various categories such as Excellence Awards, Individual Awards, and Team Awards, identifying the best of the best in the industry.

WuXi Biologics has won two awards at the 2023 APAC Bioprocessing Excellence Awards (ABEA) ceremony: “Best Contract Development and Manufacturing Organization Award” and “Bioprocessing Excellence in Greater China Region Award.” This is the sixth time the company has been recognized by the ABEA. WuXi Biologics supported its clients in obtaining 123 Investigational New Drug approvals in 2022 and currently supports 17 commercial biologics and vaccines.